Lacerta Therapeutics’ Capsid Licensing and Research Collaboration Agreement with Prevail Therapeutics.

Martina Bellini North America Legal Chronicle
Tagged:

Goodwin Procter advised Lacerta Therapeutics on the deal.Lacerta Therapeutics announced its AAV capsid licensing and research collaboration agreement with Prevail Therapeutics. As a part of the…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here